Novo, S. et al. Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors? Pharmaceuticals 2009, 2, 118-124

• প্রধান লেখক: Giuseppina Novo (লেখক), Elena Raccuglia (লেখক), Antonino Mignano (লেখক), Salvatore Novo (লেখক), Giovanni Fazio (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: MDPI AG, 2011-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

In the published version "Paladini et al. reported that aliskiren 300 mg provided a sustained BP-lowering effect beyond the 24-h dosing interval, with a significantly smaller loss of BP-lowering effect in the 24-48 h period after dose than irbesartan 300 mg or ramipril 10 mg [25]". Paladin...